Camber Specialty Capabilities
In 2022, Hetero and Camber Pharmaceuticals established Camber Specialty in response to the growing demand for high-quality, low-cost specialty medications supporting hospitals, clinics, oncology treatment centers, government, and other institutional customers.
Learn more about Camber Specialty in this short video.
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year